Section 19 · Monograph

Olanzapine

Reviewed Nov 2026FDA label
ZyprexaAtypical antipsychotic
Forms
Tab: 2.5, 5, 7.5, 10, 15, 20mg | ODT | IM: 10mg
Dose
Delirium or refractory nausea (off-label): 2.5-5mg at bedtime or divided; titrate cautiously
MOA
D2, 5-HT2A, H1 and muscarinic antagonism

Black Box Warning

  • Increased mortality in elderly patients with dementia-related psychosis; not approved for dementia-related psychosis

Indications

  • Schizophrenia and bipolar I disorderFDA-labeled
  • Agitation associated with schizophrenia or bipolar mania (IM)FDA-labeled
  • Chemotherapy-induced nausea and vomiting (with other agents) in some guidelinesFDA-labeled

Off-Label Uses

  • Delirium and refractory nausea in palliative and neurologic careOff-label

Mechanism of Action

  • Atypical antipsychotic with D2, 5-HT2A, histamine H1, muscarinic and alpha-1 receptor antagonism

Full Dosing

Adult / usual

  • Delirium or nausea (off-label): 2.5-5mg at bedtime or divided twice daily; titrate cautiously
  • Start 2.5mg in older or frail patients; ODT forms are useful when swallowing is difficult
  • Monitor sedation and orthostasis

Contraindications

  • Hypersensitivity to olanzapine
  • IM olanzapine: concurrent parenteral benzodiazepine use is not recommended (cardiorespiratory depression)

Drug Interactions

  • Additive sedation with benzodiazepines, opioids and alcohol
  • Avoid in Parkinson's disease and dementia with Lewy bodies where possible (worsens motor symptoms)
  • CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) raise levels; smoking lowers levels

Adverse Effects

  • Sedation, weight gain and metabolic effects
  • Orthostatic hypotension
  • Anticholinergic effects
  • Extrapyramidal symptoms (less than haloperidol)
  • Hyperglycemia

Monitoring Parameters

  • Sedation, orthostatic blood pressure and extrapyramidal symptoms
  • Weight, glucose and lipids with long-term use
  • Delirium or nausea response

Pregnancy & Lactation

  • Limited data; third-trimester exposure may cause neonatal extrapyramidal or withdrawal symptoms
  • Present in milk; monitor infants

References

  1. ZYPREXA (olanzapine) Prescribing Information — DailyMed (NIH) search

Same class

Please visitfamilydeckofcards.com